. The ratio and coupling efficacy of ET A and ET B receptors to the contractile apparatus of muscle cells may vary across species, vascular regions, and vessel size, as well as with the concentration of ET-1 (1, 6, 13, 15). Fukuroda et al. (6) reported that ET A receptors were dominant in the human pulmonary artery, whereas ET B receptors were dominant in the rabbit pulmonary artery. Because both receptor types are coupled G proteins, they activate several signaling pathways, including phospholipase C (PLC), resulting in generation of inositol 1,4,5-trisphosphate (IP 3 ) and 1,2-diacylglycerol (DAG) (2, 23, 24). These molecules in turn cause an increase in the intracellular concentration of Ca 2ϩ ([Ca 2ϩ ] i ), which activates protein kinase C (PKC) and leads to the contraction of smooth muscle (35, 42) . However, the cellular mechanisms by which the ET-1 receptors induce an increase in [Ca 2ϩ ] i in smooth muscle cells remain unclear. ET-1 could increase [Ca 2ϩ ] i by stimulating Ca 2ϩ influx through the plasmalemma (10, 45) and/or by causing Ca 2ϩ to be released from internal Ca 2ϩ stores (30, 41). The present study was designed to investigate 1) the source of the Ca 2ϩ that is mobilized by ET-1, 2) the ET-1 receptor subtype(s) that mediates the effects of ET-1, and 3) the intracellular mechanisms that underlie the response of smooth muscle cells to ET-1.
]i. This response was not abolished by the voltage-dependent Ca 2ϩ channel blocker nicardipine or removal of Ca 2ϩ from the bath solution but was inhibited by ryanodine and thapsigargin. This finding suggested that the increase in [Ca 2ϩ ]i induced by ET-1 was attributable to release of Ca 2ϩ from ryanodineand inositol 1,4,5-trisphosphate-sensitive intracellular Ca 2ϩ stores. The transient increase in [Ca 2ϩ ]i induced by ET-1 was also inhibited by pretreatment with antagonists of ET type A and B (ET A and ETB) receptors (BQ-123 and BQ-788, respectively). Furthermore, the ET B receptor agonist IRL-1620 induced an increase in [Ca 2ϩ ]i that was followed by a sustained increase in [Ca 2ϩ ]i; the sustained increase in [Ca 2ϩ ]i was blocked by nicardipine. Using the nystatin-perforated patch-clamp technique, we found that IRL-1620 caused an increase in Ca 2ϩ current that was inhibited by addition of ET-1. ET-1 did not inhibit Ca 2ϩ current when cells were pretreated with BQ-123. These results suggested that when both receptor types are activated, the opposing responses lead to abolition of the sustained [Ca 2ϩ ]i increases induced by ET B receptor activation. Western blot analysis confirmed expression of ET A and ETB receptors. Finally, U-73122 inhibited the ET-1-induced [Ca 2ϩ ]i increase, indicating that phospholipase C was involved in modulation of the ET-1-induced [Ca 2ϩ ]i increase in rabbit pulmonary artery smooth muscle cells. endothelin receptors; voltage-dependent Ca 2ϩ channel ENDOTHELIN (ET)-1, the most potent vasoconstrictor described to date, is a 21-amino acid peptide secreted by the vascular endothelium (44) . After release from the endothelium, ET-1 induces smooth muscle contraction by binding to ET receptor type A or B (ET A or ET B ) receptors. ET A receptors are present only on smooth muscle cells, whereas ET B receptors are located on endothelial and smooth muscle cells (35) . Studies of the roles of the two receptor subtypes in mediating the effects of ET-1 have produced highly variable results that range from exclusive mediation by one of the receptor subtypes to an equivalent contribution by both types (4, 5, 22, 29, 31, 33, 45) . The ratio and coupling efficacy of ET A and ET B receptors to the contractile apparatus of muscle cells may vary across species, vascular regions, and vessel size, as well as with the concentration of ET-1 (1, 6, 13, 15) . Fukuroda et al. (6) reported that ET A receptors were dominant in the human pulmonary artery, whereas ET B receptors were dominant in the rabbit pulmonary artery. Because both receptor types are coupled G proteins, they activate several signaling pathways, including phospholipase C (PLC), resulting in generation of inositol 1,4,5-trisphosphate (IP 3 ) and 1,2-diacylglycerol (DAG) (2, 23, 24) . These molecules in turn cause an increase in the intracellular concentration of Ca 2ϩ ([Ca 2ϩ ] i ), which activates protein kinase C (PKC) and leads to the contraction of smooth muscle (35, 42) . However, the cellular mechanisms by which the ET-1 receptors induce an increase in [Ca 2ϩ ] i in smooth muscle cells remain unclear. ET-1 could increase [Ca 2ϩ ] i by stimulating Ca 2ϩ influx through the plasmalemma (10, 45) and/or by causing Ca 2ϩ to be released from internal Ca 2ϩ stores (30, 41) . The present study was designed to investigate 1) the source of the Ca 2ϩ that is mobilized by ET-1, 2) the ET-1 receptor subtype(s) that mediates the effects of ET-1, and 3) the intracellular mechanisms that underlie the response of smooth muscle cells to ET-1.
MATERIALS AND METHODS
Cell isolation. The procedure was carried out in accordance with the guidelines of the European Community on the ethical use of animals, and all experimental procedures were reviewed and approved by the Committee for Animal Experiments of the Seoul National University College of Medicine. New Zealand White rabbits (2-2.5 kg) of either gender were anesthetized with pentobarbital sodium (50 mg/kg). The lungs were removed immediately and immersed in normal Tyrode solution containing 143 mM NaCl, 5.4 mM KCl, 0.33 mM NaH 2PO4, 1.8 mM CaCl2, 1.2 mM MgCl2, 5 mM HEPES, and 16.6 mM glucose (pH adjusted to 7.4 with NaOH). Small pulmonary arteries (Ͻ200 m OD), derived after the third or fourth branching points of the intralobar pulmonary arteries in the lower lobe on either side of the lung, were isolated by dissection under a dissecting microscope. The arteries were incubated at 37°C in the first digestion medium (Ca 2ϩ -free Tyrode solution containing 1.0 mg/ml papain, 1.0 mg/ml bovine serum albumin, and 1.0 mg/ml dithiothreitol) for 20 min and in the second digestion medium (Ca 2ϩ -free Tyrode solution containing 1.5 mg/ml collagenase, 1.0 mg/ml bovine serum albumin, and 1.0 mg/ml dithiothreitol) for 25 min. 
where R is the ratio of the fluorescence signals (405/490), Rmin is 405/490 in Ca 2ϩ -free medium containing 10 mM EGTA (ratio ϭ 0.8), Rmax is 405/490 in the presence of saturating Ca 2ϩ (ratio ϭ 7.5), and ␤ is the ratio of the 490-nm fluorescence signal measured in a Ca 2ϩ -free solution to that measured in a Ca 2ϩ -replete solution (ratio ϭ 8.2). The Ca 2ϩ dissociation constant (Kd) was determined to be 250 nM at 37°C for this dye and optical system. All experiments were carried out at room temperature (22-25°C).
Perforated-patch recordings. Membrane currents were recorded using a patch-clamp amplifier (Axopatch 1C, Axon Instrument, Union, CA). Pulse protocols and data acquisition were performed by a digital interface (Digidata 1200, Axon Instrument) coupled to an IBM-compatible microcomputer. The current signals were filtered at 0.5-1 kHz, and the sampling rate was 1-3 kHz. For the perforatedpatch recordings of the voltage-dependent Ca 2ϩ currents, the cells were bathed in a solution containing 120 mM NaCl, 2 mM CaCl2, 5 mM CsCl, 20 mM TEA-Cl, 0.5 mM MgCl2, 10 mM HEPES, and 10 mM glucose (pH adjusted to 7.4 with NaOH). The patch pipettes were filled with a solution containing 130 mM CsCl, 10 mM HEPES, 10 mM EGTA, and 5 mM Mg-ATP (pH adjusted to 7.2 with CsOH). Nystatin was added to a fresh aliquot of the pipette solution every 2 h to give a final concentration of 200 g/ml. Inward currents through voltage-gated Ca 2ϩ channels were recorded by application of a depolarizing pulse to 0 mV for 300 ms from the holding potential of Ϫ80 mV every 10 s. Membrane capacitance was determined using 10-mV voltage-clamp steps from a holding potential of Ϫ60 mV, and the current amplitudes were normalized using the membrane capacitance. The average cell capacitance was 14.9 Ϯ 1.59 (SE) pF (n ϭ 24).
Western blot analysis. Sections of the rabbit pulmonary arteries were homogenized in a hand-held microtissue grinder (Pyrex, Corning Life Sciences, Acton, MA) in two volumes of ice-cold storage buffer (100 mM KPO 4, 1 mM EDTA, 1 mM dithiothreitol, 0.1 mM phenylmethylsulfonyl fluoride, and 30% glycerol, pH 7.25). The homogenates were centrifuged at 3,500 g for 15 min at 4°C. The supernatants were colleted and stored at Ϫ80°C until use in Western blot analysis. Aliquots of pulmonary artery homogenates containing 20 g of protein were separated by electrophoresis on 10% SDS-polyacrylamide gels. The gels were transferred to Immobilon-P membranes (Millipore), which were blocked overnight in Tris-buffered saline (20 mM Tris and 150 mM NaCl, pH 8.0) containing 5% nonfat dry milk and then probed with antiserum to ␤-tubulin, ET A receptor, or ETB receptor at 1:200 dilution for 1 h at room temperature. The membranes were then incubated with horseradish peroxidase-conjugated goat anti-mouse (for ␤-tubulin) or mouse anti-goat (for ET A and ETB receptors) antibody at 1:1,000 dilution for 1 h at room temperature. The bands were visualized using an enhanced chemiluminescence Western blotting detection kit (Amersham Biosciences, Piscataway, NJ).
Chemicals and drugs. Indo 1-AM was purchased from Molecular Probes (Eugene, OR), collagenase from Wako Pure Chemical Industries (Osaka, Japan), and antisera to ET A and ETB and mouse anti-goat antibody from Santa Cruz Biotechnology (Santa Cruz, CA). All other chemicals were obtained from Sigma Chemical (St. Louis, MO).
Statistics. Values are means Ϯ SE. Differences were examined for significance using Student's t-test. P Ͻ 0.05 was considered statistically significant. ] i of 28.6 Ϯ 2.8 nM (n ϭ 8), 46.9 Ϯ 2.5 nM (n ϭ 11), and 82.4 Ϯ 3.7 nM (n ϭ 15) at 0.25, 0.5, and 5 nM ET-1, respectively (Fig.  1, A and B) . [Ca 2ϩ ] i increased to 176.1 Ϯ 5.6 nM (n ϭ 18) in cells that were depolarized with 100 mM KCl (Fig. 1D) , indicating that the cells were responsive and that the sarcoplasmic reticulum was loaded with Ca 2ϩ (35, 38) . After they were washed for 15 min, the cells were exposed to ET-1. To determine whether the ET-1-induced increase in [Ca 2ϩ ] i required Ca 2ϩ influx through voltage-dependent channels, 5 nM ET-1 was applied 10 min after the start of exposure to 5 M nicardipine, an L-type Ca 2ϩ channel antagonist. Nicardipine had no effect on the ET-1-induced increase in [Ca 2ϩ ] i (n ϭ 6; ] i increase induced by ET-1 (n ϭ 7; Fig. 1D ] i increase was attenuated in the presence of 10 M ryanodine ( Fig. 2A) . In addition, pretreatment of the cells with 10 M thapsigargin completely abolished the ET-1-induced [Ca 2ϩ ] i increase (Fig. 2B) . These results (summarized in Fig. 2C) Fig. 3E Fig. 4C ) compared with the control value. This effect was completely inhibited by 1 M BQ-788 (n ϭ 8; Fig. 4A ) and could be reversed on washout of IRL-1620 (data not shown), which suggested that IRL-1620 increased I Ca mainly via activation of ET B receptors. Addition of 30 nM ET-1 alone had no significant effect on I Ca (n ϭ 12; Fig. 4B ), but the increase in I Ca induced by 100 nM IRL-1620 was markedly attenuated by 30 nM ET-1 (n ϭ 14; Fig. 4, D and E) . Addition of 1 M BQ-123 did not affect basal I Ca (data not shown); however, in cells pretreated with 1 M BQ-123, I Ca activated by 100 nM IRL-1620 was not inhibited by 30 nM ET-1 (n ϭ 6; Fig. 4 , F and G), which suggested that the inhibition of I Ca caused by ET-1 in the absence of BQ-123 occurred via ET A receptor activation, rather than a nonspecific effect. These observations indicated that the absence of a sustained increase in [Ca 2ϩ ] i in response to ET-1 may be the result of activation of ET A receptors, which masks the Ca 2ϩ influx through Ca 2ϩ channels activated by ET B receptors. To exclude the possibility that IRL-1620 activates I Ca directly, rather than through the ET B receptor, we examined the effect of ET-1 on I Ca in the presence of the ET A antagonist BQ-123. ET-1 increased I Ca by 45.3 Ϯ 4.3% (n ϭ 5; Fig. 4, H and I ) in the absence of ET A activity, which suggested that ET B receptor activation could increase I Ca .
RESULTS

Transient
ET A and ET B receptors are expressed in pulmonary artery smooth muscle cells. To confirm that rabbit pulmonary artery smooth muscle cells expressed ET A and ET B receptors, we performed an immunoblot analysis of pulmonary membrane proteins using anti-ET A and anti-ET B affinity-purified antisera. Each antiserum recognized protein bands of the expected molecular mass, indicating that both receptor subtypes are expressed in rabbit pulmonary artery smooth muscle cells (Fig.  5) ] i increase (n ϭ 4; Fig. 6A ), which suggested that the ET-1-induced increase in [Ca 2ϩ ] i involved activation of PLC. In addition, incubation of cells with U-73122 caused a complete inhibition of the IRL-1620-induced [Ca 2ϩ ] i increase (n ϭ 4; Fig. 6C ). Also, treatment with U-73122 completely inhibited the I Ca activated by IRL-1620 (n ϭ 5; Fig. 6E ). Basal I Ca was not affected by treatment with U-73122 (data not shown), which suggested that effects on [Ca 2ϩ ] i and I Ca induced by ET B receptor activation involved PLC. Stimulation of PLC in response to the occupation of ET-1 receptors is associated with generation of IP 3 and DAG; the latter activates multiple effectors via PKC phosphorylation, including ryanodine receptors and L-type Ca 2ϩ channels (11, 43) .
DISCUSSION
We characterized the cellular mechanisms that underlie ET-1-induced increases in [Ca 2ϩ ] i in rabbit pulmonary artery smooth muscle cells. ET-1 induced a transient increase in [Ca 2ϩ ] i that was followed by a return to baseline levels. Our results revealed patterns of changes in [Ca 2ϩ ] i that are distinct from those reported elsewhere. For example, ET-1 was reported to induce a large transient [Ca 2ϩ ] i increase followed by a sustained plateau that remained elevated above baseline (8, 34) , and other studies reported oscillations in [Ca 2ϩ ] i in smooth muscle cells in response to ET-1 (3, 16) . This discrepancy is most likely attributable to differences in the wide variety of models used to study Ca 2ϩ regulation, which include freshly isolated cells, cultured cells, and different cell types. Godfraind (9) suggested that ET A receptors mediate constriction in smaller, preresistance arteries, whereas more than one ET receptor is involved in the larger segments. In contrast, Adner and colleagues (1) indicated a dominance of ET B receptors in the human peripheral lung. Therefore, participation of ET-1 receptor subtypes might differ according to artery diameter, which is attributed to the different pattern of [Ca 2ϩ ] i response to ET-1. In our study, we clarified the effect of ET-1-induced [Ca 2ϩ ] i increases on Ͻ200-m third-to fourthorder pulmonary resistance arteries. We found that ET A muscle (10, 18, 34) . However, other evidence suggested that inhibitors of L-type voltage-gated Ca 2ϩ channels did not inhibit the ET-1-induced [Ca 2ϩ ] i increase or the contraction of vascular smooth muscle (25, 32) .
In the present study, BQ-788 completely inhibited the ET-1-induced [Ca 2ϩ ] i increase (Fig. 3B) , which suggested that the activation of ET B receptors is necessary for the ET-1-induced increase in [Ca 2ϩ ] i . However, the patterns of changes in [Ca 2ϩ ] i induced by IRL-1620 from those induced by ET-1. IRL-1620 induced a sustained, rather than a transient, [Ca 2ϩ ] i increase. The sustained component resulted from Ca 2ϩ influx through voltage-dependent Ca 2ϩ channels, because it was abolished when cells were treated with nicardipine (Fig. 3E) . Using the nystatin-perforated patch-clamp technique, we found that the activation of ET B receptors increased I Ca and that I Ca was inhibited by the activation of ET A receptors. Our data suggested that the two subtypes of ET-1 receptors produce increases in [Ca 2ϩ ] i that are the net result of a complex interaction between the regulation of Ca 2ϩ channels by each receptor subtype. The opposing effects of ET A and ET B receptors on [Ca 2ϩ ] i lead to the elimination of a sustained [Ca 2ϩ ] i increase when both receptors are activated.
In this study, we found that IRL-1620 had no effect on I Ca measured using the whole cell patch-clamp technique (data not shown). Such differences in experimental techniques have contributed to the apparent discrepancies in the reported results. The perforated patch-clamp recording allows I Ca to be studied without the movement of large intracellular molecules and structures that occurs with the rupture of the cell membranes required in the whole cell patch-clamp technique (14, 21 In general, the ET- (26, 27) . However, further investigations should explore whether activation of the PLC pathway results in the generation of two second messengers, IP 3 and DAG, which are involved in intracellular Ca 2ϩ release and PKC activation, respectively. In conclusion, we have demonstrated that ET-1 induces the release of Ca 2ϩ from intracellular stores in rabbit pulmonary Fig. 5 . Immunoblot analysis of expression of ETA and ETB receptors in rabbit endothelium-denuded pulmonary arteries. Western blotting was performed using anti-ETA and anti-ETB receptor antibodies. 45-kDa immunoreactive band corresponds to the known molecular size of the ETA receptor; 50-kDa immunoreactive band corresponds to the known molecular size of the ETB receptor. artery smooth muscle cells via activation of ET A and ET B receptors. In addition, ET-1 was functionally coupled to a rise in [Ca 2ϩ ] i through activation of PLC.
